SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is facing significant selling pressure after Marvell canceled all existing purchase orders, citing a breach of confidentiality obligations following public disclosures by company management. The community is actively debating whether this is a structural failure for the company's optics technology or an orchestrated exit by Marvell to favor internal alternatives, with many investors calling for immediate management accountability.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is rallying to new all-time highs as the market heavily bets on the company's central role in the ongoing AI infrastructure supercycle. Investors and traders are aggressively chasing momentum, with active community discussions highlighting the stock's massive market cap growth, the potential for sustained demand, and a general consensus that it remains the benchmark for the broader semiconductor sector.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. It operates through the following segments: Seed and Integrated Products, Crop Protection, Crop Nutrition, and Emerging Solutions. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science is experiencing extreme volatility driven by its nano-float status, which has triggered aggressive retail buying and short-squeeze chatter. The community is focused on the potential for parabolic moves as they monitor tight share availability and surging borrow fees in hopes of replicating past low-float run-ups.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond is seeing heightened volatility and social media attention following an acquisition announcement involving tokens.com and ongoing strategic efforts to build an "Everything Home" ecosystem. While some investors are betting on a turnaround fueled by management's push for integration and RWA tokenization, others remain skeptical, citing continued cash burn and concerns over shareholder dilution.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to a major acquisition announcement involving European Lithium, which aims to consolidate 100% ownership of the Tanbreez project while strengthening the company's cash position. The community is actively debating the implications of this corporate restructuring, with many bulls expecting reduced dilution and improved institutional appeal to catalyze significant upside momentum.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS) segments. The ATS segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The CCS segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is experiencing significant volatility as investors weigh a strong earnings beat and raised annual guidance against broader concerns over AI sector valuation and increased capital expenditure plans. While the community is actively debating the stock's long-term growth potential and 

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors aggressively position themselves ahead of upcoming earnings, with high-conviction options activity and excitement surrounding its strategic integration of AI across cloud and search. The stock is also drawing interest due to its massive, often-overlooked equity stakes in high-profile ventures like SpaceX and Anthropic, reinforcing its status as a foundational player in the AI infrastructure and compute ecosystem.

High-Trend International Group is a holding company. It engages in shipping decarbonization and carbon asset management platforms. The company was founded in 2021 and is headquartered in Singapore.

High-Trend International Group. - Ordinary Shares - Class A

HTCO is seeing intense volatility and social media buzz driven by speculative trading and high-frequency momentum shifts, with community discussions heavily split between optimistic traders targeting further squeeze potential and skeptics labeling the stock as a transient pump and dump. Investors are closely monitoring the low-float nature of the shares, which continues to fuel aggressive price swings and frequent halts.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently the center of community discussion following its historic first-ever point-to-point eVTOL demonstration flights in New York City, sparking intense debate between long-term investors highlighting this milestone and traders debating the stock's short-term volatility and institutional short interest. While proponents point to successful testing and robust partnerships as evidence of a leading position in the urban air mobility sector, others remain focused on the stock's recent price consolidation and the broader risks associated with the pre-revenue industry.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus Inc. (RMBS) is experiencing significant downward pressure following its recent earnings report, where a revenue-impacting supply chain issue prompted investor concerns and profit-taking after a month of strong, AI-driven gains. While the community remains divided between those viewing the pullback as an opportunity to accumulate shares in a key memory infrastructure player and those concerned about the company's execution and high valuation, the stock is seeing elevated trading volume as market participants re-evaluate its long-term positioning within the data center ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ZYME ZW191 AACR update:

The breakout 📈speaks for itself. 
Float is verysmall on this one.

ZW191 AACR update:

• 61% cORR in platinum-resistant ovarian cancer (6.4–9.6 mg/kg)
• Early Elahere ~30% ORR pooled / 47% selected subgroup → ZW191 showing stronger early efficacy signal
• 100% disease control in optimized ovarian/endometrial cohorts
• 1.4 month time to response = fast activity
• 6.4 mg/kg emerging as likely sweet spot
• Ongoing optimization trial now key catalyst: goal is preserve efficacy while lowering AEs
• If durability holds + safety improves, ZW191 could become a serious next-gen FRα challenger

I’m a bagholder and wont be  selling :-)

$ZYME #biotech #oncology

Mike Long

Tony Tony

Ian B

ScoobieDoo

StockTwits for iOS

Zymeworks Inc

 ZW191 AACR update:

The breakout 📈speaks for itself. 
Float is verysmall on this one.

ZW191 AACR update:

• 61% cORR in platinum-resistant ovarian cancer (6.4–9.6 mg/kg)
• Early Elahere ~30% ORR pooled / 47% selected subgroup → ZW191 showing stronger early efficacy signal
• 100% disease control in optimized ovarian/endometrial cohorts
• 1.4 month time to response = fast activity
• 6.4 mg/kg emerging as likely sweet spot
• Ongoing optimization trial now key catalyst: goal is preserve efficacy while lowering AEs
• If durability holds + safety improves, ZW191 could become a serious next-gen FRα challenger

I’m a bagholder and wont be  selling :-)



Lordstock

@mostbullish  Totally appreciate your input. It&#39;s a crowded field and some with deep pockets. Are you able to share some insight on competitors in FR⍺ such as Lilly&#39;s sofetabart mipitecan (LY4170156), Astra’s torvuta-S, and Genmab&#39;s Rina-S? Thank you so much

StockTwits Web

  Totally appreciate your input. It's a crowded field and some with deep pockets. Are you able to share some insight on competitors in FR⍺ such as Lilly's sofetabart mipitecan (LY4170156), Astra’s torvuta-S, and Genmab's Rina-S? Thank you so much

@tdntdn $ZYME Yes FRa is a crowded field and ZW191 is behind all 3. All in phase 3 if i recall.  ZW is strong but discontinuations and hematologic toxicity must come down in the optimization trial. Right now LLY&#39;s sofetabart is the main competitor with good effect in low and high FRa. Byt they are all 4 very similar, with the exception that ZW191s data is early, others form ph2 optimization trials. Rina-s look great but mostly so fare outside ovarian. I prolly not buy Zymeworks only for ZW191 but what zw191 does , is making ZW into a platform play.

 Yes FRa is a crowded field and ZW191 is behind all 3. All in phase 3 if i recall.  ZW is strong but discontinuations and hematologic toxicity must come down in the optimization trial. Right now LLY's sofetabart is the main competitor with good effect in low and high FRa. Byt they are all 4 very similar, with the exception that ZW191s data is early, others form ph2 optimization trials. Rina-s look great but mostly so fare outside ovarian. I prolly not buy Zymeworks only for ZW191 but what zw191 does , is making ZW into a platform play.

@mostbullish Thank you so much for the feedback. Appreciate you.

StockTwits For Android 

 Thank you so much for the feedback. Appreciate you.